[1] Leung WK, Gao L, Siu PM, et al. Diabetic nephropathy and endothelial dysfunction: Current and future therapies, and emerging of vascular imaging for preclinical renal-kinetic study[J]. Life Sci, 2016, 166:121-130.
[2] Mou X, Zhou DY, Liu YH, et al. Study on the relationship between chinese medicine constitutive susceptibility and diversity of syndrome in diabetic nephropathy[J]. Chin J Integr Med, 2013,19(9):656-662.
[3] Pei Z, Deng Q, Babcock SA, et al. Inhibition of advanced glycation endproduct (AGE) rescues against streptozotocin-induced diabetic cardiomyopathy: Role of autophagy and ER stress[J]. Toxicol Lett, 2017, 284:10-20.
[4] Li W, Cui M, Wei Y, et al. Inhibition of the expression of TGF-β1 and CTGF in human mesangial cells by exendin-4, a glucagon-like peptide-1 receptor agonist[J]. Cell Physiol Biochem, 2012, 30(3):749-757.
[5] 张诚. 通心络超微粉联合津力达颗粒对糖尿病大鼠的肾脏防治作用及其对TGF-β1/Smad信号转导通路的影响[D]. 河北医科大学, 2014.
[6] Franconi F, Seghieri G, Canu S, et al. Are the available experimental models of type 2 diabetes appropriate for a gender perspective [J] ? Pharmacol Res, 2008, 57(1):6-18.
[7] Cui F, Zou D, Gao Y, et al. Effect of Tongxinluo on nephrin expression via inhibition of Notch1/Snail pathway in diabetic rats[J]. Evid Based Complement Alternat Med, 2015, 2015:424193.
[8] Ogurtsova K, da Rocha Fernandes JD, Huang Y, et al. IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040[J]. Diabetes Res Clin Pract, 2017, 128:40-50.
[9] Hosseini SM, Boright AP, Sun L, et al. The association of previously reported polymorphisms for microvascular complications in a meta-analysis of diabetic retinopathy[J]. Hum Genet, 2015, 134(2):247-257.
[10]Faherty N, Curran SP, O'Donovan H, et al. CCN2/CTGF increases expression of miR-302 microRNAs, which target the TGF-β type II receptor with implications for nephropathic cell phenotypes[J]. J Cell Sci, 2012, 125(Pt 23):5621-5629.
[11]Mohan T, Velusamy P, Chakrapani LN, et al. Impact of EGCG supplementation on the progression of diabetic nephropathy in rats: An insight into fibrosis and apoptosis [J]. J Agric Food Chem, 2017, 65(36):8028-8036.
[12]Galvan DL, Badal SS, Long J, et al. Real-time in vivo mitochondrial redox assessment confirms enhanced mitochondrial reactive oxygen species in diabetic nephropathy[J]. Kidney Int, 2017, 92(5):1282-1287.
[13]Sakai K, Jawaid S, Sasaki T, et al. Transforming growth factor-β-independent role of connective tissue growth factor in the development of liver fibrosis[J]. Am J Pathol, 2014, 184(10):2611-2617.
[14]Zhang D, Shao S, Shuai H, et al. SDF-1α reduces fibronectin expression in rat mesangial cells induced by TGF-β1 and high glucose through PI3K/Akt pathway[J]. Exp Cell Res, 2013, 319(12):1796-1803.
[15]Wang JY, Gao YB, ZHANG N, et al. Tongxinluo ameliorates renal structure and function by regulating miR-21-induced epithelial-mesenchymal transition in diabetic nephropathy[J]. Am J Physiol, Renal physiol, 2014, 35(4):513-522.
[16]Cheng L, Cheng Z, Wang Y, et al. Paeoniflorin exerts a nephroprotective effect on concanavalin A-induced damage through inhibition of macrophage infiltration[J]. Diagn Pathol,2015, 10(1):120.
[17]Mao N, Cheng Y, Shi XL, et al. Ginsenoside Rg1 protects mouse podocytes from aldosteronein-duced injury in vitro[J]. Acta pharmacol Sin, 2014, 35(4):513-522.
[18]Sun Q, Meng QT, Jiang Y, et al. Protective effect of ginsenoside Rb1 against intestinal ischemia-reperfusion induced acute renal injury in mice[J]. PloS One, 2013, 8(12):e80859. |